title: TNF inhibitors improve muscle lactate production upon maximal effort in spondyloarthritis: An open labelled study.
authors.affiliation: Rheumatology department, hôpital Sud, CHU Grenoble Alpes, avenue de Kimberley, BP 338, 38434 Échirolles cedex, France. Electronic address: rgastaldi@chu-grenoble.fr.
authors.forename: Romain
authors.initials: R
authors.lastname: Gastaldi
authors.affiliation: Sport medicine department, CHU Grenoble Alpes, Grenoble, France; University Grenoble Alpes, Hypoxie et Physiopathologie, 38000 Grenoble, France; Inserm, U1042, 38000 Grenoble, France.
authors.forename: Michel
authors.initials: M
authors.lastname: Guinot
authors.affiliation: Sport medicine department, CHU Grenoble Alpes, Grenoble, France; University Grenoble Alpes, Hypoxie et Physiopathologie, 38000 Grenoble, France; Inserm, U1042, 38000 Grenoble, France.
authors.forename: Sébastien
authors.initials: S
authors.lastname: Baillieul
authors.affiliation: Rheumatology department, hôpital Sud, CHU Grenoble Alpes, avenue de Kimberley, BP 338, 38434 Échirolles cedex, France; GREPI, université Grenoble Alpes, EA7408, 38000 Grenoble, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Gaudin
authors.affiliation: Rheumatology department, hôpital Sud, CHU Grenoble Alpes, avenue de Kimberley, BP 338, 38434 Échirolles cedex, France; GREPI, université Grenoble Alpes, EA7408, 38000 Grenoble, France.
authors.forename: Athan
authors.initials: A
authors.lastname: Baillet
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use; D000328:Adult; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D000068800:Etanercept / Q000627:therapeutic use; D015444:Exercise / Q000502:physiology*; D005260:Female; D006801:Humans; D000069285:Infliximab / Q000627:therapeutic use; D019344:Lactic Acid / Q000096:biosynthesis* / Q000097:blood; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D025241:Spondylarthritis / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D015415:Biomarkers; D014409:Tumor Necrosis Factor-alpha; D019344:Lactic Acid; D000069285:Infliximab; D000068879:Adalimumab; D000068800:Etanercept
keywords: Cardiovascular risk; Exercise; Insulin resistance; Spondyloarthritis; TNF inhibitors